170 related articles for article (PubMed ID: 8958801)
41. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
42. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
[TBL] [Abstract][Full Text] [Related]
44. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.
Timms JM; Bell A; Flavell JR; Murray PG; Rickinson AB; Traverse-Glehen A; Berger F; Delecluse HJ
Lancet; 2003 Jan; 361(9353):217-23. PubMed ID: 12547545
[TBL] [Abstract][Full Text] [Related]
45. CD30 expression and survival in posttransplant lymphoproliferative disorders.
Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
[No Abstract] [Full Text] [Related]
46. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?
Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH
Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151
[TBL] [Abstract][Full Text] [Related]
47. [Study on EB virus infection, LMP1 and Bcl-2 expression in lung cancer patients].
Li CM; Zhang SJ; Zhu JH; Han GL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):277-9. PubMed ID: 22097606
[TBL] [Abstract][Full Text] [Related]
48. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Sternberg-like cells in non-Hodgkin's lymphomas and reactive conditions.
Chetty R; Biddolph S; Gatter K
Hum Pathol; 1997 Apr; 28(4):493-8. PubMed ID: 9104951
[TBL] [Abstract][Full Text] [Related]
49. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.
Murray PG; Swinnen LJ; Constandinou CM; Pyle JM; Carr TJ; Hardwick JM; Ambinder RF
Blood; 1996 Jan; 87(2):706-11. PubMed ID: 8555494
[TBL] [Abstract][Full Text] [Related]
50. Expression of p16/INK4a in posttransplantation lymphoproliferative disorders.
Martin A; Baran-Marzak F; El Mansouri S; Legendre C; Leblond V; Charlotte F; Davi F; Canioni D; Raphaël M
Am J Pathol; 2000 May; 156(5):1573-9. PubMed ID: 10793069
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis.
Chen FF; Yan JJ; Lai WW; Jin YT; Su IJ
Cancer; 1998 Jun; 82(12):2334-42. PubMed ID: 9635525
[TBL] [Abstract][Full Text] [Related]
52. Lack of correlation between expression of Epstein-Barr virus (EBV) latent membrane protein and bcl-2 oncoprotein in vivo.
Tao Q; Srivastava G; Loke SL; Ho FC
J Clin Pathol; 1994 Jul; 47(7):589-91. PubMed ID: 8089211
[TBL] [Abstract][Full Text] [Related]
53. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment.
Petrara MR; Giunco S; Serraino D; Dolcetti R; De Rossi A
Cancer Lett; 2015 Dec; 369(1):37-44. PubMed ID: 26279520
[TBL] [Abstract][Full Text] [Related]
54. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M
Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261
[TBL] [Abstract][Full Text] [Related]
55. Latent membrane protein 1, tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF-2, TRAF-3, and nuclear factor kappa B expression in posttransplantation lymphoproliferative disorders.
Ramalingam P; Chu WS; Tubbs R; Rybicki L; Pettay J; Hsi ED
Arch Pathol Lab Med; 2003 Oct; 127(10):1335-9. PubMed ID: 14521460
[TBL] [Abstract][Full Text] [Related]
56. [Epstein-Barr virus infection and the expression of bcl-2 proto-oncogene in Hodgkin's disease].
Liu C; Liao S; Gao Z
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):155-7. PubMed ID: 10072857
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients.
Dockrell DH; Strickler JG; Paya CV
Clin Infect Dis; 1998 Jan; 26(1):180-2. PubMed ID: 9455529
[TBL] [Abstract][Full Text] [Related]
58. Low apoptotic index & bak expression in EBV-associated childhood classical Hodgkin lymphoma.
Dinand V; Malik A; Mohanty B; Chander B; Arya LS; Dawar R
Indian J Med Res; 2009 Nov; 130(5):526-32. PubMed ID: 20090100
[TBL] [Abstract][Full Text] [Related]
59. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina--correlation with Epstein Barr virus presence.
Preciado MV; Cristobal E; Menarguez J; Martinez Montero JC; Diez B; De Matteo E; Grinstein S
Pathol Res Pract; 1998; 194(1):25-31. PubMed ID: 9542744
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES
Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
